Novo vs. Eli Lilly: Valuation Trade Opportunity

On this week’s episode of The Morning Filter podcast, Dave Sekera and Susan Dziubinski recap volatile 2025 and preview what may lie ahead in 2026. They discuss what to watch this week, including the earnings report from stock pick Constellation Brands STZ. They unpack Morningstar’s recent 50% fair value increase on Micron Technology MU stock, review results from Darden Restaurants DRI and FedEx FDX, and discuss whether Novo Nordisk NVO or Eli Lilly LLY is the better obesity drug stock to buy today. 

Dave shares some of his favorite resources for stock investors. They close with a discussion about stocks that make good core holdings: Tune in to learn which five core stocks look like attractive buys in the new year.

Episode Highlights 

00:00 Welcome

01:16 2025 Market Recap 

21:20 Micron’s Big Fair Value Increase 

32:34 Top Resources for Stock Investors 

39:05 Core Stocks to Buy and Hold

Read about topics from this episode. 

December 2025 Stock Market Outlook: Where We See Investment Opportunities

Read Dave’s complete archive.

Got a question for Dave? Send it to themorningfilter@morningstar.com.

Follow us on social media.

Dave Sekera on X: @MstarMarkets

Dave Sekera on LinkedIn: https://www.linkedin.com/in/davesekera

Facebook: https://www.facebook.com/MorningstarInc/

X: https://x.com/MorningstarInc

Instagram: https://www.instagram.com/morningstarinc/?hl=en

LinkedIn: https://www.linkedin.com/company/morningstar/posts/?feedView=all

Viewers who’d like more information about any of the stocks Dave talked about today can visit Morningstar.com for more details. Read more fromSusan Dziubinski and Dave Sekera.

Subscribe to The Morning Filter to get notified when we post. We’ll see you next Monday!

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.